Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 3
2008 3
2010 3
2011 6
2012 2
2013 3
2014 4
2015 2
2016 5
2017 3
2019 4
2020 5
2021 12
2022 7
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Design, development, and validation of multi-epitope proteins for serological diagnosis of Zika virus infections and discrimination from dengue virus seropositivity.
Pereira SH, Sá Magalhães Serafim M, Moraes TFS, Zini N, Abrahão JS, Nogueira ML, Coelho Dos Reis JGA, Bagno FF, da Fonseca FG. Pereira SH, et al. Among authors: da fonseca fg. PLoS Negl Trop Dis. 2024 Apr 18;18(4):e0012100. doi: 10.1371/journal.pntd.0012100. eCollection 2024 Apr. PLoS Negl Trop Dis. 2024. PMID: 38635656 Free PMC article.
Taming the SARS-CoV-2-mediated proinflammatory response with BromAc®.
Ferreira GM, Clarindo FA, Ribeiro ÁL, Gomes-de-Pontes L, de Carvalho LD, Martins-Filho OA, da Fonseca FG, Teixeira MM, Sabino AP, Eapen MS, Morris DL, Valle SJ, Coelho-Dos-Reis JGA. Ferreira GM, et al. Among authors: da fonseca fg. Front Immunol. 2023 Dec 13;14:1308477. doi: 10.3389/fimmu.2023.1308477. eCollection 2023. Front Immunol. 2023. PMID: 38193087 Free PMC article.
New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19.
de Almeida Marques DP, Andrade LAF, Reis EVS, Clarindo FA, Moraes TFS, Lourenço KL, De Barros WA, Costa NEM, Andrade LM, Lopes-Ribeiro Á, Coêlho Maciel MS, Corrêa-Dias LC, de Almeida IN, Arantes TS, Litwinski VCV, de Oliveira LC, Serafim MSM, Maltarollo VG, Guatimosim SC, Silva MM, Tsuji M, Ferreira RS, Barreto LV, Barbosa-Stancioli EF, da Fonseca FG, De Fátima Â, Coelho-Dos-Reis JGA. de Almeida Marques DP, et al. Among authors: da fonseca fg. Virus Res. 2024 Feb;340:199291. doi: 10.1016/j.virusres.2023.199291. Epub 2023 Dec 14. Virus Res. 2024. PMID: 38065303 Free PMC article.
Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine.
Dias Assis BR, Gomes IP, de Castro JT, Rivelli GG, de Castro NS, Gomez-Mendoza DP, Bagno FF, Hojo-Souza NS, Chaves Maia AL, Lages EB, da Fonseca FG, Ribeiro Teixeira SM, Fernandes AP, Gazzinelli RT, Castro Goulart GA. Dias Assis BR, et al. Among authors: da fonseca fg. Nanomedicine (Lond). 2023 Aug;18(18):1175-1194. doi: 10.2217/nnm-2023-0122. Epub 2023 Sep 15. Nanomedicine (Lond). 2023. PMID: 37712604 Clinical Trial.
Synthesis of cannabidiol-based compounds as ACE2 inhibitors with potential application in the treatment of COVID-19.
Marques GVL, Marques DPA, Clarindo FA, Avendaño-Villarreal JA, Guerra FS, Fernandes PD, Dos Santos EN, Gusevskaya EV, Kohlhoff M, Moreira FA, Andrade LAF, Fonseca FGD, Dos-Reis JGAC, Oliveira RB. Marques GVL, et al. Among authors: fonseca fgd. Eur J Med Chem. 2023 Nov 15;260:115760. doi: 10.1016/j.ejmech.2023.115760. Epub 2023 Aug 28. Eur J Med Chem. 2023. PMID: 37657273
RT-qPCR-based pool testing for the diagnosis of COVID-19.
Sato HI, Costa MS, Takahashi RHC, Lourenço KL, Guimarães NS, Alves CRL, Machado EL, Tupinambás U, Fonseca FGD, Teixeira SMR. Sato HI, et al. Among authors: fonseca fgd. Einstein (Sao Paulo). 2023 Jul 10;21:eAE0115. doi: 10.31744/einstein_journal/2023AE0115. eCollection 2023. Einstein (Sao Paulo). 2023. PMID: 37436266 Free PMC article.
72 results